Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

Background and Aim Remimazolam tosilate (RT) is a new short‐acting GABA(A) receptor agonist, having potential to be an effective option for procedural sedation. Here, we aimed to compare the efficacy and safety of RT with propofol in patients undergoing upper gastrointestinal endoscopy. Methods This...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology Jg. 36; H. 2; S. 474 - 481
Hauptverfasser:	Chen, Shao‐Hui, Yuan, Tang‐Mi, Zhang, Jiao, Bai, Hua, Tian, Ming, Pan, Chu‐Xiong, Bao, Hong‐Guang, Jin, Xiao‐Ju, Ji, Fu‐Hai, Zhong, Tai‐Di, Wang, Qiang, Lv, Jian‐Rui, Wang, Sheng, Li, Yu‐Juan, Yu, Yong‐Hao, Luo, Ai‐Lin, Li, Xiang‐Kui, Min, Su, Li, Lin, Zou, Xiao‐Hua, Huang, Yu‐Guang
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Australia Wiley Subscription Services, Inc 01.02.2021
Schlagworte:	Adverse events Anesthesia benzodiazepine endoscopic sedation Endoscopy GABA (A) receptor agonist Hypotension Propofol remimazolam remimazolam tosilate Safety Success upper gastrointestinal endoscopy γ-Aminobutyric acid GABA (A) receptor agonist remimazolam remimazolam tosilate endoscopic sedation upper gastrointestinal endoscopy benzodiazepine
ISSN:	0815-9319, 1440-1746, 1440-1746
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!